Myelodysplastic syndromes trials in Australia

In Australia 17 Also abroad 368

17 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Where
Adelaide, Box Hill, Douglas, Fitzroy, Garran, Melbourne, Parkville, Sydney
Age
18 years and over
People
225 worldwide
Run by
Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00
Phase 3Taking people
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
Where
Adelaide, Bedford Park, Clayton, Coffs Harbour, Fitzroy, Heidelberg, Perth, Richmond, Sydney, Waratah
Age
18 years and over
People
300 worldwide
Run by
Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00
Phase 1Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Where
Macquarie University, Melbourne, Nedlands, Randwick
Age
18 years and over
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00
Phase 1Taking people
A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS
Where
Clayton, Fitzroy, Melbourne, Nedlands, Perth
Age
18 years and over
People
100 worldwide
Run by
Apollo Therapeutics Ltd
See details and how to joinNCT06372717
Phase 1/2Taking people
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Where
Fitzroy, Perth
Age
16 years and over
People
85 worldwide
Run by
AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00
Phase 1/2Taking people
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Where
Nedlands, Saint Albans, Sydney, West Perth
Age
18 years and over
People
150 worldwide
Run by
Disc Medicine, Inc
See details and how to joinNCT05320198
Phase 2Taking people
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Where
Adelaide, Albury, Bedford Park, Box Hill, Douglas, Geelong, Heidelberg, Melbourne, Tweed Heads, Wendouree, Westmead
Age
18 years and over
People
210 worldwide
Run by
Takeda
See details and how to joinNCT04419649 · EU 2023-507469-24-00
Phase 3Taking people
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Where
Blacktown, Cooloongup, Epping, Heidelberg, Kingswood, Liverpool, Melbourne, Perth, Richmond, Waratah
Age
18 years and over
People
490 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00
Phase 2Taking people
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Where
Kingswood, Melbourne N., Southport
Age
18 years and over
People
140 worldwide
Run by
Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00
Phase 1/2Taking people
A Study of BGB-11417 in Participants With Myeloid Malignancies
Where
Clayton, Concord, Fitzroy, Heidelberg, Kogarah, Melbourne, Murdoch, Nedlands, Orange, Southport
Age
18 years and over
People
260 worldwide
Run by
BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00
Phase 3Taking people
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Where
Adelaide, Clayton, Epping, Liverpool, Nedlands, Waratah
Age
18 years and over
People
48 worldwide
Run by
Institut de Recherches Internationales Servier
See details and how to joinNCT06465953 · EU 2023-510155-37-00
Phase 1/2Taking people
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Where
Parkville, Perth, South Brisbane, Westmead
Age
Up to 22 years
People
960 worldwide
Run by
PedAL BCU, LLC
See details and how to joinNCT04726241
Phase 1Taking people
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Where
Perth, Sydney
Age
18 years and over
People
266 worldwide
Run by
Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT06656494
Phase 3Taking people
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Where
Adelaide, Camperdown, Clayton, South Brisbane
Age
18 years and over
People
665 worldwide
Run by
Celgene
See details and how to joinNCT04064060
Phase 1/2Taking people
Study to Evaluate the Safety and Tolerability of EP0042
Where
Perth
Age
18 years and over
People
70 worldwide
Run by
Ellipses Pharma
See details and how to joinNCT04581512 · EU 2024-514588-24-00
Phase 1Taking people
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
Where
Sydney, Westmead
Age
18 years and over
People
12
Run by
Clinical Hub for Interventional Research (CHOIR)
See details and how to joinNCT05636514
Phase 1/2Taking people
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Where
Albury, Fitzroy, Herston, Nedlands, Townsville
Age
18 years and over
People
240 worldwide
Run by
Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00